HealthCor Catalio Acquisition Corp.
Completed 2021-12-21- CIK 1833769
- HCAQ
- IPO 2021-01-28
- $207M trust
- 366 filings
Successfully merged with Hyperfine, Inc. and Liminal Sciences, Inc.
- IPO Size
- $180M
- raised at the IPO
- Trust
- $207M
- as of 2021-09-30
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
366 filings over 24 quarters; violet bars carry a milestone
- 20 Q4: 1 filing
- 21 Q1: 22 filings
- 21 Q2: 1 filing
- 21 Q3: 23 filings
- 21 Q4: 57 filings
- 22 Q1: 35 filings
- 22 Q2: 17 filings
- 22 Q3: 15 filings
- 22 Q4: 41 filings
- 23 Q1: 16 filings
- 23 Q2: 15 filings
- 23 Q3: 10 filings
- 23 Q4: 10 filings
- 24 Q1: 9 filings
- 24 Q2: 14 filings
- 24 Q3: 4 filings
- 24 Q4: 3 filings
- 25 Q1: 9 filings
- 25 Q2: 16 filings
- 25 Q3: 4 filings
- 25 Q4: 9 filings
- 26 Q1: 9 filings
- 26 Q2: 20 filings
- 26 Q3: 6 filings
- S-1 filed 20 Q4
- IPO 21 Q1
- Definitive agreement 21 Q3
- Completed 21 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
HealthCor Catalio Acquisition Corp. is a blank-check company formed to effect a business combination with one or more businesses. It intends to focus broadly on the healthcare industry, especially life sciences and medical technology.
Investment Focus
Healthcare
Geographic Focus
United States
Key Information
As the filings state it
- IPO Date
- 2021-01-28
- Total Redemptions
- $171M
- PIPE
- $126M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2021-12-21
- Merger Target
- Hyperfine, Inc. and Liminal Sciences, Inc.
- SPAC Ticker
- HCAQ
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team combines the healthcare investment and research experience of HealthCor with Catalio’s private-equity and biomedical technology network, including investment managers, healthcare company executives, and doctors and scientists.